Overtreatment of prostate cancer in the active surveillance era
Common Sense Family Doctor
DECEMBER 14, 2024
in 2020, with higher percentages of patients with more favorable pathology or lower PSA levels choosing one of these strategies. Time spent diagnosing, monitoring, and treating asymptomatic prostate cancer in men with limited life expectancy distracts from monitoring and treating their symptomatic life-limiting illnesses.
Let's personalize your content